| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 15, 2005
Revised on September 8, 2005
Accepted on September 22, 2005
From the Department of Pharmacology (H.T.-J., Y.R., S.S.), School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel; The Nephrology (T.N.-M.) and Endocrinology & Metabolism (N.K.) Services, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and Department of Clinical Biochemistry and Pathobiochemistry (J.E.), German Diabetes Center, Düsseldorf, Germany.
* To whom correspondence should be addressed. E-mail: sassolo{at}cc.huji.ac.il.
Substrate autoregulation of glucose transporter-1 (GLUT-1) mRNA and protein expression provides vascular endothelial and smooth muscle cells a sensitive mechanism to adapt their rate of glucose transport in response to changing glycemic conditions. Hyperglycemia-induced downregulation of glucose transport is particularly important in protecting these cells against an excessive influx of glucose and consequently increased intracellular protein glycation and generation of free radicals; both are detrimental in the development of vascular disease in diabetes. We aimed to investigate the molecular mechanism of high glucose-induced downregulation of GLUT-1 mRNA expression in primary bovine aortic vascular endothelial (VEC) and vascular smooth muscle (VSMC) cell cultures. Using RNA mobility shift, UV cross-linking, and in vitro degradation assays, followed by mass-spectrometric analysis, we identified calreticulin as a specific destabilizing trans-acting factor that binds to a 10-nucleotide cis-acting element (CAE2181 to 2190) in the 3'-untranslated region of GLUT-1 mRNA. Pure calreticulin accelerated the rate of GLUT-1 mRNA-probe degradation in vitro, whereas overexpression of calreticulin in vascular cells decreased significantly the total cell content of GLUT-1 mRNA and protein. The expression of calreticulin was augmented in vascular cells exposed to high glucose in comparison with low-glucose conditions. Similarly, increased expression of calreticulin was observed in aortae of diabetic Psammomys obesus in comparison with normoglycemic controls. These data suggest that CAE2181 to 2190-calreticulin complex, which is formed in VSMC and VEC exposed to hyperglycemic conditions, renders GLUT-1 mRNA susceptible to degradation. This interaction underlies the process of downregulation of glucose transport in vascular cells under high-glucose conditions.
Related Article:
This article has been cited by other articles:
![]() |
V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, H. Fei, N. C. Connors, J. Zhang, and I. B. Levitan Drosophila Ortholog of Succinyl-CoA Synthetase {beta} Subunit: A Novel Modulator of Drosophila KCNQ Channels J Neurophysiol, May 1, 2008; 99(5): 2736 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yokoyama and K.-i. Hirata New Function of Calreticulin: Calreticulin-Dependent mRNA Destabilization Circ. Res., November 11, 2005; 97(10): 961 - 963. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |